Ineffective antibiotic therapy due to biofilm infections can now be effectively treated through the use of hyperbaric oxygen therapy

A relatively new category of chronic infections caused by bacteria growing in slime-enclosed aggregates known as biofilms is now becoming one of the major focus topics in clinical research, as it affects millions of people in the developed world each year and in turn is responsibilities for many deaths as a result. Biofilm infections can be extremely difficult to treat, particularly in cases such as pneumonia in cystic fibrosis patients, chronic wounds, chronic otitis media and implant- and catheter-associated infections.

“The findings in this study highlight that oxygenation by HBOT improves the bactericidal activity of ciprofloxacin on P. aeruginosa biofilm and suggest that bacterial biofilms is sensitized to antibiotics by supplying hyperbaric O2.

Read more about the study here…

About the Author

Dr. Zayd Ratansi, ND
Dr. Zayd Ratansi is a licensed Naturopathic Physician with advanced certifications in hyperbaric medicine, bio-oxidative medicine, low level light therapy, chelation therapy and environmental medicine. He specializes in the treatment of brain injuries and other neurological conditions using hyperbaric oxygen therapy.
Dr. Ratansi has worked with hyperbaric therapy for over 18 years and is widely regarded as a world authority on hyperbaric therapy, and more recently targeted hyperbaric therapy. He lectures worldwide on the use of hyperbaric oxygen therapy for neurological conditions and has played a leading role in implementing protocols on the use of hyperbaric therapy in the mainstream medical setting.
His passion is to share scientific information on hyperbaric therapy to give the public greater empowerment to make their own choices on whether or not hyperbaric therapy would be appropriate for them, while also helping to facilitate the safest access to hyperbaric therapy to gain the most therapeutic benefit.